Transient hypoplastic anemia caused by primary human parvovirus B19 infection in a previously untreated patient with hemophilia transfused with a plasma-derived, monoclonal antibody-purified factor VIII concentrate.

Abstract

BACKGROUND Modern plasma-derived clotting factor concentrates are produced using various virus-inactivation protocols and are assumed to be safer than they were previously with regard to the risk for transmitting viral infections such as human immunodeficiency virus, hepatitis B, and hepatitis C. The risks from viruses that are relatively resistant to the… (More)

Topics

Cite this paper

@article{Matsui1999TransientHA, title={Transient hypoplastic anemia caused by primary human parvovirus B19 infection in a previously untreated patient with hemophilia transfused with a plasma-derived, monoclonal antibody-purified factor VIII concentrate.}, author={Hideo Matsui and M Sugimoto and Shingo Tsuji and Masayuki Shima and John C. Giddings and Akira Yoshioka}, journal={Journal of pediatric hematology/oncology}, year={1999}, volume={21 1}, pages={74-6} }